Maze Therapeutics, Inc. (MAZE) — Stock Price, Chart & Analysis
Maze Therapeutics, Inc. (MAZE) is a Healthcare stock currently trading at $28.38, up 26.75% on the day. It carries a market capitalization of $1.58B. Over the past 52 weeks, MAZE has traded between $21.95 and $53.65. Maze Therapeutics, Inc. does not currently pay a regular dividend. View the live MAZE chart, technical opinion, analyst ratings, fundamentals and latest news below.
Maze Therapeutics, Inc. (MAZE) key data
| Price | $28.38 |
| Change (today) | +26.75% |
| Previous close | $22.39 |
| Market cap | $1.58B |
| EPS (TTM) | $-3.09 |
| 52-week high | $53.65 |
| 52-week low | $21.95 |
| Avg. volume | 549.1K |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently asked questions about Maze Therapeutics, Inc. (MAZE)
How much does one share of Maze Therapeutics, Inc. cost?
As of the latest update, one share of Maze Therapeutics, Inc. (MAZE) trades at $28.38 (+26.75% today).
What is Maze Therapeutics, Inc.'s market cap?
Maze Therapeutics, Inc. has a market capitalization of approximately $1.58B.
What is Maze Therapeutics, Inc.'s earnings per share (EPS)?
Maze Therapeutics, Inc.'s trailing twelve-month EPS is $-3.09.
Does Maze Therapeutics, Inc. pay a dividend?
Maze Therapeutics, Inc. does not currently pay a regular dividend.
What is Maze Therapeutics, Inc.'s 52-week trading range?
Over the past year, MAZE has traded between $21.95 and $53.65.
What is the analyst price target for Maze Therapeutics, Inc.?
The mean analyst price target for Maze Therapeutics, Inc. is $62.55. This is informational only and not investment advice.
Latest Maze Therapeutics, Inc. (MAZE) news
- Maze Therapeutics Chief Medical Officer Dumps Entire Direct Stake in the Company for $255,000News · Sep 11, 2026
- Maze Therapeutics to Participate in Three Upcoming Investor ConferencesNews · Sep 2, 2026
- Maze Therapeutics Announces Appointments to Its Board of DirectorsNews · Aug 13, 2026
- Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent HighlightsNews · Aug 11, 2026
- Can Maze Therapeutics, Inc. (MAZE) Climb 120.48% to Reach the Level Wall Street Analysts Expect?News · Jul 21, 2026
- What Does the Maze Therapeutics CEO's Sale of Nearly 30,000 Shares Mean for Investors?News · Jun 29, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live MAZE dashboard…